Delivery Order SPE2DE24D0021-SPE2D626F81D4
- Not listed
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $3,300 for the provision of SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits, with an ultimate completion date of February 17, 2026. This fixed-price contract with economic price adjustment was issued by the Department of Defense's Medical Supply Chain on December 17, 2025, and will be performed at Fisher Scientific's principal facility in Pittsburgh, Pennsylvania. No set-aside designation was applied to this...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,650 for SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits by the Department of Defense's Medical Supply Chain. This fixed-price contract with economic price adjustment provisions is effective through January 27, 2026, and represents a child order under Fisher Scientific's existing blanket purchase agreement vehicle. No set-aside designation was applied to this award, indicating open competition. The...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $3,300 for the procurement of SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits under a contract with the Department of Defense's Medical Supply Chain. The award, issued on December 8, 2025, is structured as a fixed-price contract with economic price adjustment provisions and carries an ultimate completion date of February 5, 2026. This delivery order represents a child contract with no set-aside...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $3,300 for the supply of SOFIA 2 FLU + SARS antigen fluorescent diagnostic test kits under a fixed-price contract with economic price adjustment. The award, issued on December 3, 2025, with an ultimate completion date of February 2, 2026, was made by the Department of Defense's Medical Supply Chain. Performance will occur in Pittsburgh, Pennsylvania. This delivery order represents a child contract under a larger...
- Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order valued at $2.2K on December 4, 2025, for SOFIA 2 FLU + SARS antigen fluorescent diagnostic test kits. The contract, which carries an ultimate completion date of February 3, 2026, was issued by the Department of Defense's Medical Supply Chain without set-aside designation, indicating open competition. Performance will be fulfilled from Fisher Scientific's principal place of business in Pittsburgh, Pennsylvania. This...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $5.5K for SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits under a fixed-price contract with economic price adjustment provisions. The award, issued on October 28, 2025, with an ultimate completion date of December 26, 2025, supports the Department of Defense's Medical Supply Chain with performance conducted in Pittsburgh, Pennsylvania. This delivery order represents a child contract under a larger...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,650 on November 17, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits. This fixed-price contract with economic price adjustment is a child order under a larger indefinite delivery vehicle and will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of January 15, 2026. The award was issued by the Department of Defense's Medical Supply Chain, a defense agency supporting military...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,200 by the Department of Defense's Medical Supply Chain on December 4, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits. The contract is a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of February 3, 2026. The award is a child contract under a larger vehicle and required no set-aside designation, indicating open competition. Performance...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $2,750 by the Department of Defense's Medical Supply Chain for SOFIA 2 FLU + SARS antigen fluorescent diagnostic test kits. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of March 4, 2026. This award represents a child contract issued under a larger indefinite delivery vehicle and involves no set-aside designation, indicating...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,200 for the provision of SOFIA 2 FLU + SARS antigen fluorescent diagnostic test kits. The contract, awarded on October 29, 2025, with an ultimate completion date of December 29, 2025, operates under a fixed-price structure with economic price adjustment provisions. The award was issued by the Department of Defense's Medical Supply Chain and does not utilize a set-aside designation, indicating open competitive procurement....
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D626F81D4Delivery Order
Fisher Scientific Company L.L.C. was awarded a delivery order valued at $3,300 on January 6, 2026, for SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits under a fixed-price contract with economic price adjustment provisions. The award, issued by the Department of Defense's Medical Supply Chain, is scheduled for completion by March 5, 2026, and will be performed in Pittsburgh, Pennsylvania. This delivery order represents a child contract under a larger vehicle and was awarded without set-aside designation, indicating open competition. Fisher Scientific, a major federal scientific and laboratory supplies vendor registered in the System for Award Management since July 2001, has an extensive track record supplying diagnostic equipment and medical supplies across multiple federal agencies including the Department of Veterans Affairs and Department of Defense. The contract supports the federal government's medical supply chain operations, providing diagnostic testing capabilities for influenza and SARS antigen detection. Fisher Scientific's established position as a critical supplier of specialized laboratory instruments and diagnostic test kits across federal healthcare and research organizations demonstrates the company's capability to meet government procurement requirements. The relatively modest delivery order value and short performance timeline are consistent with the company's routine role in supplying consumable diagnostic products to federal medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 1/5/26 |